News
For the most recent news and press releases, visit our investor relations website: www.ir.icecure-medical.com
ICECURE GIVES NOTICE OF SPECIAL GENERAL MEETING FOR SHAREHOLDERS OF THE COMPANY
Notice is hereby given of the convening of a special general meeting for the shareholders of IceCure, to be held on Sunday, September 1, 2019,
ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.
Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of
IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association
New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.
IceCure featured in the leading interventional oncology news outlet, Interventional News
IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News.
IceCure presents promising results from first-ever Interventional Radiology study
Data presented at the European Association of Urology showed the ProSense™ system at 1-year follow-up was safe, effective and without serious adverse events for treating
IceCure featured in the leading news education publication, Healio
The promise of cryotherapy as an alternative treatment for a specific group of [patients with] breast cancer.” Kenneth Tomkovich MD, radiologist at Princeton Radiology and
ICECURE GIVES NOTICE OF SPECIAL GENERAL MEETING FOR SHAREHOLDERS OF THE COMPANY
Notice is hereby given of the convening of a special general meeting for the shareholders of IceCure, to be held on Sunday, September 1, 2019,
ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.
Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of
IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association
New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.
IceCure featured in the leading interventional oncology news outlet, Interventional News
IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News.
IceCure presents promising results from first-ever Interventional Radiology study
Data presented at the European Association of Urology showed the ProSense™ system at 1-year follow-up was safe, effective and without serious adverse events for treating
IceCure featured in the leading news education publication, Healio
The promise of cryotherapy as an alternative treatment for a specific group of [patients with] breast cancer.” Kenneth Tomkovich MD, radiologist at Princeton Radiology and